Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Research into Hepatitis B seroprevalence among children aged 1-18 years in Usak province and comparison with seroprevalence in other provinces and Turkey

Selcuk Gurel, Mehmet Ucar.




Abstract

Hepatitis B (HBV) infection is a significant health problem around the world. Turkey is a country with moderate endemicity. This study aims to investigate the seroprevalence of HBV and anti-Hbs seropositivity among children and young adults aged 1 to 18 years living in Usak province of Turkey. This is a retrospective review of 720 children, 394 boys and 326 girls, aged 1 to 18 years who were admitted to Usak Private Medical Park Hospital for any reason between January 2017 and December 2018. Anti-Hbs seropositivity was identified in 471 children including 63% of the boys (249/394) and 68% of the girls (222/326) in the study cohort. Only one case of HbsAg positivity (0.001%) was specified among 720 children. Anti-Hbs seropositivity was 83% in Group 1 (82/99), 61% in Group 2 (62/101), 55% in Group 3 (51/92), 56% in Group 4 (43/77) and 66% in Group 5 (233/350). To the best of our knowledge, this hospital-based cross-sectional study is the first clinical research of the 1-18-year age group for HbsAg seroprevalence and anti-Hbs seropositivity in Usak province. When compared with other provinces and Turkey in general, HbsAg seropositivity rate is relatively low in this study.

Key words: HBV, seroprevalence, childhood, vaccination






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.